首页 | 本学科首页   官方微博 | 高级检索  
检索        

加替沙星和左氧氟沙星序贯治疗尿路感染的成本-效果比较
引用本文:易红,石庆平,龙恩武.加替沙星和左氧氟沙星序贯治疗尿路感染的成本-效果比较[J].中国药业,2009,18(17):41-43.
作者姓名:易红  石庆平  龙恩武
作者单位:1. 核工业四一六医院,四川,成都,610051
2. 蚌埠医学院第一附属医院药剂科,安徽,蚌埠,233004
3. 四川省医学科学院·四川省人民医院,四川,成都,610072
摘    要:目的对加替沙星和左氧氟沙星序贯治疗尿路感染进行成本-效果比较分析。方法将85例尿路感染患者随机分成两组,A组42例给予加替沙星序贯疗法,B组43例给予左氧氟沙星序贯疗法,运用药物经济学方法最小成本-效果分析。结果A组和B组的总有效率分别为85.71%和88.37%,细菌清除率分别为90.48%和93.02%,不良反应发生率分别为7.14%和4.65%,成本效果比分别为2.42和1.87。结论对于尿路感染患者,采用左氧氟沙星序贯疗法比加替沙星序贯疗法具成本-效果优势,值得临床应用推广。

关 键 词:加替沙星  左氧氟沙星  尿路感染  药物经济学分析

Pharmacoeconomical Analysis of Gatifloxacin and Levofloxacin in Impenetrate Treatment of Urinary Tract Infection
Yi Hong,Shi Qingping,Long Enwu.Pharmacoeconomical Analysis of Gatifloxacin and Levofloxacin in Impenetrate Treatment of Urinary Tract Infection[J].China Pharmaceuticals,2009,18(17):41-43.
Authors:Yi Hong  Shi Qingping  Long Enwu
Institution:1. 416 Hospital of Nuclear Industry Ministry, Chengdu, Sichuan, China 610051; 2. Department of Pharmacy, Hospital Affiliated to Bengbu Medical College, Bengbu, Anhui, China 233004; 3. Sichuan Academy of Medical Sciences, Sichuan Provincial People' s Hospital, Chengdu, Sichuan, China 610072)
Abstract:Objective To analyze the cost- effect of gatifloxacin and levofloxacin in impenetrate treatment of urinary tract infection. Methods 85 cases of urinary infection were randomly divided into 2 groups. Group A(42 cases) and group B(43 cases) were sequentially treated with gatifloxacin and levofloxacin, respectively. The cost-effect in two groups was analyzed and compared with each other by pharma- coeconomical method. Results The effective rates in gatifloxacin group and levofloxacin group were 85.71% and 88.37%, the bacterial clearance rates were 90.48% and 93.02% and adverse reaction rates were 7. 14% and 4. 65%. However, the cost- effect ratio were 2. 42 and 1.87 respectively in gatifloxacin group and levofloxacin group. Conclusion Levofloxacin has cost- effect advantage over gatifloxacin in the impenetrate treatment of urinary tract infection and deserves the clinical expansion.
Keywords:gatifloxacin  levofloxacin  urinary tract infection  pharmacoeconomical analysis
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号